Nurses & Rheumatic Disease Care: Key Role Revealed
- Barcelona research underscores the significant benefits of nurse-led care in managing rheumatic musculoskeletal diseases.
- One study focused on gout management, suggesting that combining self-monitoring with nurse support during urate-lowering therapy initiation could decrease physician visits and costs while maintaining or improving care...
- The intervention involved rheumatology nurses remotely guiding patients through dose adjustments based on at-home serum urate testing.
Discover the critical role nurses play in revolutionizing rheumatic disease care. New research highlights how nurse-led initiatives and self-monitoring strategies significantly enhance patient outcomes. Studies presented at EULAR 2025 reveal that nurses, through remote monitoring and group education clinics, are not only improving patient care but also streamlining healthcare systems. These interventions, focused on conditions like gout and inflammatory arthritis, demonstrate how nurses, the primary_keyword, save time and reduce costs while maintaining or improving care quality. Furthermore, explore how a focus on nurse-led care, a secondary_keyword, is transforming approaches to biologic medication initiation.Find out how waiting times are reduced and patient satisfaction skyrockets. News Directory 3 provides unique insights into health trends. WhatS the future of nurse involvement? Discover what’s next …
Nurse-led Care Improves Outcomes for Rheumatic diseases
Barcelona research underscores the significant benefits of nurse-led care in managing rheumatic musculoskeletal diseases. Studies reveal that integrating nurse-led initiatives and self-monitoring techniques enhances patient outcomes and streamlines healthcare systems.
One study focused on gout management, suggesting that combining self-monitoring with nurse support during urate-lowering therapy initiation could decrease physician visits and costs while maintaining or improving care quality. Jeffrey van der Ven’s research, presented at EULAR 2025, explored the cost-effectiveness of nurse-led home monitoring of serum urate compared to standard secondary care.
The intervention involved rheumatology nurses remotely guiding patients through dose adjustments based on at-home serum urate testing. Conventional care relied on the same strategy but used hospital-based lab measurements and routine rheumatologist appointments.
Findings indicated that home monitoring was cost-effective,yielding a mean incremental net monetary benefit of €130. While health outcome improvements were modest, the intervention saved rheumatologists 42.7 minutes through task reallocation to nurses, who spent an additional 51.2 minutes. This time savings could enable rheumatologists to accommodate more new patients.
Researchers suggest future studies should focus on reducing nurse time while maintaining patient adherence, with automated feedback and risk stratification based on home-monitored values as potential next steps.
In the U.K., a clinic experimented with using nurses to expedite biologic initiation for inflammatory arthritis patients. Theresa May presented findings from a weekly biologic group education clinic led by a nurse practitioner, replacing individual appointments. these 30-minute group sessions, comprising 3–4 patients grouped by biologic class, covered treatment benefits, risks, side effects, governance, and monitoring.
A quality enhancement project involving 28 patients showed that waiting times from treatment decision to education appointment decreased from 46 to 10 days after implementing group education clinics. The weekly clinic capacity increased from 6 to 12–18 patients, with minimal administrative impact. patients reported the sessions were useful, interactive, and engaging, particularly valuing peer support.
patients rated the session’s overall quality 9.85 out of 10 and thier confidence in biologic knowledge after the session as 9.42. The authors concluded that nurse-led biologic group education clinics are a feasible and effective intervention for reducing waiting times and improving patient satisfaction.
More data:
van der Ven J, et al. cost-effectiveness of nurse-led home monitoring of serum uric acid values for gout patients in secondary care: a modelling study. Presented at EULAR 2025; OP0303.DOI: 10.1136/annrheumdis-2025-eular.B3248
Alcala TM, et al. Nurse-led Biologic Group Education Clinic for patients with inflammatory arthritis: A Quality improvement Project. Presented at EULAR 2025; OP0118-HPR. Two: 10.1136/Annrheumdis-2025-eul.C138
